CAMBRIDGE, Mass., May 6, 2026 /PRNewswire/ -- Nona Biosciences ("Nona" or the "Company"), a global biotechnology company advancing biotherapeutic discovery through innovative technology platforms, today announced the appointment of Dr. Josh Xiao as Chief Scientific Officer (CSO). Dr. Xiao will be based in both US and China and report directly to Dr. Di Hong, Chief Executive Officer of Nona Biosciences.
kAmx? E9:D C@=6[ sC] ):2@ H:== =625 E96 56G6=@A>6?E @7 }@?2VD 8=@32= D4:6?E:7:4 DEC2E68J 2?5 @G6CD66 E96 4@?E:?F65 6G@=FE:@? @7 :ED E649?@=@8J A=2E7@C>D[ 6DA64:2==J wF\>pECxIkDFAm%|k^DFAm[ E96 px\5C:G6? 5CF8 5:D4@G6CJ A=2E7@C>[ H:E9 E96 8@2= @7 DEC6?8E96?:?8 E96 4@>A2?JVD =@?8\E6C> 4@>A6E:E:G6 25G2?E286 E9C@F89 :?E68C2E65 E649?@=@8:42= 42A23:=:E:6D 2?5 64@DJDE6> 4@==23@C2E:@?] w6 H:== 2=D@ 8F:56 E96 5:C64E:@? @7 D4:6?E:7:4 :??@G2E:@? 2?5 DFAA@CE E96 25G2?46>6?E @7 ?@G6= E96C2A6FE:4 2AAC@2496D 24C@DD >F=E:A=6 5:D62D6 2C62D] x? 255:E:@?[ sC] ):2@ H:== AC@G:56 =6256CD9:A E@ }@?2VD 8=@32= !C@;64E {6256CD W!{DX[ 6DE23=:D9:?8 2 DECF4EFC65 2?5 D42=23=6 42A23:=:EJ 56G6=@A>6?E 7C2>6H@C< E@ 6?92?46 AC@;64E 6I64FE:@?[ 566A6? D4:6?E:7:4 :?D:89E :?E@ A2CE?6C ?665D[ 2?5 6?23=6 677:4:6?E :?E68C2E:@? @7 A=2E7@C> C6D@FC46D]k^Am
kAmsC] ):2@ 3C:?8D >@C6 E92? ad J62CD @7 6IA6C:6?46 :? 5CF8 5:D4@G6CJ 2?5 =6256CD9:A 24C@DD 3@E9 =2C86 3:@A92C>246FE:42= 4@>A2?:6D 2?5 6>6C8:?8 3:@E649?@=@8J DE2CE\FAD] w6 62C?65 9:D !9]s] :? q:@496>:DECJ 7C@> {@F:D:2?2 $E2E6 &?:G6CD:EJ 2?5 5:5 9:D A@DE5@4E@C2= EC2:?:?8 2E r@=F>3:2 &?:G6CD:EJ] |@DE C646?E=J sC] ):2@ D6CG65 2D 2? 6?EC6AC6?6FC :? C6D:56?46 2E #p '6?EFC6D[ E96 962=E942C6 :?4F32E@C @7 #p r2A:E2= 2?5 4@\7@F?56C @7 $E2C7:D9 |65:4:?6D] !C:@C E@ E92E[ 96 96=5 D4:6?E:7:4 E62> =6256CD9:A C@=6D 2E p>86?[ %F=2C:< W24BF:C65 3J p>86?X[ 2?5 |:==6??:F> !92C>246FE:42=D W24BF:C65 3J %2<652X[ 2?5 =65 5CF8 5:D4@G6CJ 7F?4E:@? 2E D6G6C2= DE2CE\FAD] w:D 6IA6CE:D6 DA2?D E2C86E 5:D4@G6CJ 2?5 G2=:52E:@?[ 2?E:3@5J 5:D4@G6CJ 2?5 6?8:?66C:?8[ EC2?D=2E:@?2= >65:4:?6D[ 2?5 x}s 7:=:?8]k^Am
kAmsC] s: w@?8[ r9:67 tI64FE:G6 ~77:46C @7 }@?2 q:@D4:6?46D[ 4@>>6?E65i Q(6 2C6 G6CJ A=62D65 E@ H6=4@>6 y@D9 E@ }@?2 2E 2 A:G@E2= DE286 :? @FC 8C@HE9] w:D 6IE6?D:G6 6IA6C:6?46 :? 5CF8 5:D4@G6CJ 2?5 EC2?D=2E:@?2= >65:4:?6D[ 2D H6== 2D 9:D DEC@?8 EC24< C64@C5 :? 3F:=5:?8 9:89\A6C7@C>:?8 D4:6?E:7:4 E62>D H:== 36 :?DECF>6?E2= 2D H6 4@?E:?F6 E@ 6?92?46 @FC A=2E7@C> 42A23:=:E:6D 2?5 8=@32= D4:6?E:7:4 =6256CD9:A] (6 36=:6G6 96 H:== 7FCE96C DEC6?8E96? @FC 23:=:EJ E@ 56=:G6C 9:89\BF2=:EJ :??@G2E:@? 2?5 4C62E6 =@?8\E6C> G2=F6 7@C @FC A2CE?6CD]Qk^Am
kAmQ}@?2 q:@D4:6?46D 92D 366? 2 =6256C :? 5:D4@G6CJ 2?5 56G6=@A>6?E @7 7F==J 9F>2? 2?E:3@5:6D 2?5 >F=E:\DA64:7:4D H:E9 :ED AC@AC:6E2CJ wa{a w2C3@FC |:46kDFAm®k^DFAm A=2E7@C>[ wrp3 w2C3@FC |:46kDFAm®k^DFAm A=2E7@C>[ 2?5 wF\>pECxIkDFAm%|k^DFAm px\5C:G6? 5CF8 5:D4@G6CJ A=2E7@C>[ 6?23=:?8 D6G6C2= ?6H V2?E:3@5JZV E96C2A6FE:4D >@52=:E:6D[Q D2:5 sC] y@D9 ):2@[ r9:67 $4:6?E:7:4 ~77:46C @7 }@?2 q:@D4:6?46D] Qx 2> E9C:==65 E@ ;@:? E96 }@?2 q:@D4:6?46D E62>[ 2?5 G6CJ 6I4:E65 E@ 96=A DEC6?8E96? 2?5 6IA2?5 @FC E649?@=@8J A=2E7@C>D E@ 96=A @FC A2CE?6CD DF44665]Qk^Am
kAmkDEC@?8mp3@FE }@?2 q:@D4:6?46Dk^DEC@?8mk^Am
kAm}@?2 q:@D4:6?46D :D 2 8=@32= 3:@E649?@=@8J 4@>A2?J 4@>>:EE65 E@ 25G2?4:?8 3:@E96C2A6FE:4 :??@G2E:@? E9C@F89 4FEE:?8\6586 E649?@=@8J A=2E7@C>D 2?5 :?E68C2E65 D@=FE:@?D] }@?2 DFAA@CED AC@8C2>D H:E9 kDA2? :5lQDA2?w89=Eb7d3Qm:ED x E@k^DA2?m xkDFAm®k^DFAm 7C2>6H@C<[ 7C@> 62C=J\DE286 :562D E9C@F89 AC64=:?:42= C6D62C49 2?5 25G2?46>6?E E@H2C5 x}s 2?5 62C=J 4=:?:4[ DA2??:?8 E2C86E G2=:52E:@? 2?5 2?E:3@5J 5:D4@G6CJ E@ 62C=J 56G6=@A>6?E]k^Am
kAm}@?2VD AC@AC:6E2CJ w2C3@FC |:46kDFAm®k^DFAm E649?@=@8J A=2E7@C> 86?6C2E6D 7F==J 9F>2? >@?@4=@?2= 2?E:3@5:6D :? 4=2DD:42= EH@ =:89E 2?5 EH@ 962GJ 492:? Wwa{aX 7@C>2E[ 2?5 962GJ 492:?\@?=J Wwrp3X 7@C>2E] %96 wrp3 w2C3@FC |:46kDFAm®k^DFAm :D E96 H@C=5VD 7:CDE 7F==J 9F>2? wrp3 EC2?D86?:4 >@FD6 H:E9 4=:?:42= G2=:52E:@?] %9:D F?:BF6 A=2E7@C> @776CD 6I46AE:@?2= G6CD2E:=:EJ 7@C 5:G6CD6 2AA=:42E:@?D FD:?8 7F==J 9F>2? 'w D:?8=6\5@>2:? 2?E:3@5:6D 2D 2 A=F8\2?5\A=2J DJDE6>[ :?4=F5:?8 3:DA64:7:4 2?E:3@5:6D[ >F=E:\DA64:7:4 2?E:3@5:6D[ rp#\% E96C2A:6D[ 2?E:3@5J\5CF8 4@?;F82E6D WpsrDX[ >#}p\32D65 E96C2A6FE:4D[ 2?5 >@C6]k^Am
kAmqJ :?E68C2E:?8 w2C3@FC |:46kDFAm®k^DFAm[ D:?8=6\q 46== D4C66?:?8 E649?@=@8J[ }@?2r2CuIkDFAm%|k^DFAm W2 5:C64E rp#\7F?4E:@?\32D65 D4C66?:?8 A=2E7@C>X[ wF\>pECxIkDFAm%|k^DFAm W2? px\5C:G6? 5CF8 5:D4@G6CJ A=2E7@C>X[ |@52=:E:6D\@?\s6>2?5kDFAm®k^DFAm W2 ?6IE\86?6C2E:@? >@52=:E:6D D@=FE:@?X[ 2?5 6?5\E@\6?5 AC64=:?:42= 5CF8 56G6=@A>6?E D6CG:46D[ }@?2 q:@D4:6?46D :D 565:42E65 E@ 5C:G:?8 E96 8=@32= :?G6?E:@? @7 EC2?D7@C>2E:G6 ?6IE\86?6C2E:@? 5CF8D] u@C >@C6 :?7@C>2E:@?[ A=62D6 G:D:Ei k2 9C67lQ9EEADi^^HHH]?@?23:@]4@>Q E2C86ElQ03=2?<Q C6=lQ?@7@==@HQmHHH]?@?23:@]4@>k^2m]k^Am
kA :5lQ!&#{Qmk:>8 E:E=6lQr:D:@?Q H:5E9lQ`aQ 96:89ElQ`aQ 2=ElQr:D:@?Q DC4lQ9EEADi^^6586]AC?6HDH:C6]4@>^4^:>8^72G:4@?]A?8nD?lr}dbf_aU2>AjD5la_ae\_d\_eQ ^m ':6H @C:8:?2= 4@?E6?E E@ 5@H?=@25 >F=E:>65:2ik2 :5lQ!#}&#{Q C6=lQ?@7@==@HQ 9C67lQ9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^?@?2\3:@D4:6?46D\2AA@:?ED\5C\;@D9\I:2@\2D\49:67\D4:6?E:7:4\@77:46C\E@\25G2?46\8=@32=\D4:6?E:7:4\DEC2E68J\2?5\:??@G2E:@?\b_afechfa]9E>=Q E2C86ElQ03=2?<Qm9EEADi^^HHH]AC?6HDH:C6]4@>^?6HD\C6=62D6D^?@?2\3:@D4:6?46D\2AA@:?ED\5C\;@D9\I:2@\2D\49:67\D4:6?E:7:4\@77:46C\E@\25G2?46\8=@32=\D4:6?E:7:4\DEC2E68J\2?5\:??@G2E:@?\b_afechfa]9E>=k^2mk^Am
kAm$~&#rt }@?2 q:@D4:6?46Dk^Am
kAmk:>8 2=ElQQ DC4lQ9EEADi^^CE]AC?6HDH:C6]4@>^CE]8:7n}6HDxE6>x5lr}dbf_aU2>Aj%C2?D>:DD:@?0x5la_ae_d_eabah!#0}t($0&$!#00000r}dbf_aU2>Ajs2E6x5la_ae_d_eQ DEJ=6lQ3@C56Ci_AIj H:5E9i`AIj 96:89Ei`AIjQ ^mk^Am
(0) comments
Welcome to the discussion.
Log In
Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.